Geeta Datta

Title: Geeta Datta: Innovator in Synthetic Apolipoprotein Research

Introduction

Geeta Datta is a prominent inventor based in Pelham, Alabama, known for her significant contributions to the field of synthetic apolipoproteins. With a total of three patents to her name, she has made remarkable strides in developing innovative solutions aimed at improving human health.

Latest Patents

Her latest patents include "Synthetic apolipoprotein E mimicking polypeptides and methods of use." This invention provides novel synthetic apolipoprotein E (ApoE)-mimicking peptides that enhance low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL) binding to and degradation by fibroblast or HepG2 cells. The potential applications of these synthetic peptides include lowering human plasma LDL/VLDL cholesterol levels, thereby inhibiting atherosclerosis. Another notable patent is "Synthetic single domain polypeptides mimicking apolipoprotein E and methods of use." This invention focuses on a synthetic apolipoprotein-E mimicking polypeptide consisting of a single domain, along with nucleic acid encoding, vectors, antibodies, and methods of use.

Career Highlights

Geeta Datta is affiliated with the UAB Research Foundation, where she continues to advance her research in synthetic peptides. Her work has garnered attention for its potential impact on cardiovascular health and cholesterol management.

Collaborations

Some of her notable coworkers include David W. Garber and Gattadahalli M. Anantharamiah, who have collaborated with her on various research projects.

Conclusion

Geeta Datta's innovative work in synthetic apolipoproteins showcases her dedication to advancing medical science and improving health outcomes. Her contributions are paving the way for future developments in cholesterol management and cardiovascular health.